Market Research Logo

Wound Closure Devices - Medical Devices Pipeline Assessment, 2018

Wound Closure Devices - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Wound Closure Devices - Medical Devices Pipeline Assessment, 2018 provides an overview of Wound Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Wound Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Wound Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Wound Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Wound Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Wound Closure Devices Overview
3 Products under Development
3.1 Wound Closure Devices - Pipeline Products by Stage of Development
3.2 Wound Closure Devices - Pipeline Products by Segment
3.3 Wound Closure Devices - Pipeline Products by Territory
3.4 Wound Closure Devices - Pipeline Products by Regulatory Path
3.5 Wound Closure Devices - Pipeline Products by Estimated Approval Date
3.6 Wound Closure Devices - Ongoing Clinical Trials
4 Wound Closure Devices - Pipeline Products under Development by Companies
4.1 Wound Closure Devices Companies - Pipeline Products by Stage of Development
4.2 Wound Closure Devices - Pipeline Products by Stage of Development
5 Wound Closure Devices Companies and Product Overview
5.1 3-D Matrix Ltd Company Overview
5.2 Actamax Surgical Materials LLC Company Overview
5.3 Adhesys Medical GmbH Company Overview
5.4 Advanced Medical Solutions Group plc Company Overview
5.5 Alafair Biosciences Inc Company Overview
5.6 Albert Ludwigs University of Freiburg Company Overview
5.7 Aleo BME Inc Company Overview
5.8 Alumend LLC Company Overview
5.9 Angiotech Pharmaceuticals Inc Company Overview
5.10 Anika Therapeutics Inc Company Overview
5.11 APRUS Bio-Medical Innovations Pvt Ltd Company Overview
5.12 ARC Medical Devices Inc. Company Overview
5.13 Arch Therapeutics Inc Company Overview
5.14 Aura Medsystems, Inc. Company Overview
5.15 Baxter International Inc Company Overview
5.16 Bayer AG Company Overview
5.17 Bergen Medical Products Inc Company Overview
5.18 Beth Israel Deaconess Medical Center Inc Company Overview
5.19 BioActive Polymers in Lund AB Company Overview
5.20 Biomedica Management Corp Company Overview
5.21 Biom'Up SAS Company Overview
5.22 Boston University Company Overview
5.23 C. R. Bard Inc Company Overview
5.24 Calmare Therapeutics Inc Company Overview
5.25 CardioCommand Inc Company Overview
5.26 Cellphire Inc Company Overview
5.27 Ceramicos Para Aplicacoes Medicas SA Company Overview
5.28 Clemson University Company Overview
5.29 Cohera Medical Inc Company Overview
5.30 Columbia University Company Overview
5.31 CorMedix Inc Company Overview
5.32 Covalent Medical, Inc. (Inactive) Company Overview
5.33 Covalon Technologies Ltd Company Overview
5.34 Covidien plc Company Overview
5.35 Cresilon Inc Company Overview
5.36 CryoLife Inc Company Overview
5.37 Daewoong Pharmaceutical Co Ltd Company Overview
5.38 Dermtreat ApS Company Overview
5.39 DSM Biomedical BV Company Overview
5.40 Elastagen Pty Ltd Company Overview
5.41 Emory University Company Overview
5.42 Emrge LLC Company Overview
5.43 Endomedix Incorporated Company Overview
5.44 Entegrion Inc Company Overview
5.45 ES Vascular Ltd. Company Overview
5.46 Ethicon Endo-Surgery Inc Company Overview
5.47 Ethicon US LLC Company Overview
5.48 ETX Pharma Inc Company Overview
5.49 FzioMed Inc Company Overview
5.50 Gamma Therapeutics Inc Company Overview
5.51 GATT Technologies BV Company Overview
5.52 Gecko Biomedical Company Overview
5.53 gel-e Inc Company Overview
5.54 Grifols SA Company Overview
5.55 Haemostatix Ltd Company Overview
5.56 Hemostasis LLC Company Overview
5.57 HyperBranch Medical Technology Inc Company Overview
5.58 Innocoll Technologies Ltd Company Overview
5.59 Institute of Molecular Biology of Parana Company Overview
5.60 Integra LifeSciences Holdings Corp Company Overview
5.61 InVivo Therapeutics Corp Company Overview
5.62 IonMed Ltd. Company Overview
5.63 Johns Hopkins University Company Overview
5.64 KeraNetics, LLC Company Overview
5.65 Kollodis BioSciences Inc Company Overview
5.66 Kuros Biosciences AG Company Overview
5.67 Kytogenics Pharmaceuticals Inc Company Overview
5.68 Laser Tissue Welding, Inc. Company Overview
5.69 Latch Medical Ltd Company Overview
5.70 Leader Biomedical Europe BV Company Overview
5.71 Lenvitz Medical Solutions Pvt. Ltd. Company Overview
5.72 Life Care Medical Devices Ltd Company Overview
5.73 LifeBond Ltd Company Overview
5.74 Luna Innovations Inc Company Overview
5.75 Magen OrthoMed Ltd Company Overview
5.76 Maxigen Biotech Inc Company Overview
5.77 Medisse BV (Inactive) Company Overview
5.78 MiMedx Group Inc Company Overview
5.79 MLM Biologics Inc Company Overview
5.80 N8 Medical Inc Company Overview
5.81 Northwestern University Company Overview
5.82 OptMed, Inc. Company Overview
5.83 PetVivo Holdings Inc Company Overview
5.84 Pharming Group NV Company Overview
5.85 Polyganics BV Company Overview
5.86 Protein Polymer Technologies Inc (Inactive) Company Overview
5.87 Regenics AS Company Overview
5.88 Resorba GmbH Company Overview
5.89 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
5.90 Rice University Company Overview
5.91 Samyang Biopharmaceuticals Corp Company Overview
5.92 Sanofi Company Overview
5.93 Sea Run Holdings Inc Company Overview
5.94 Sealantis Ltd. Company Overview
5.95 Seikagaku Corp Company Overview
5.96 Seraffix Ltd Company Overview
5.97 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.98 Sheba Medical Center Company Overview
5.99 St Teresa Medical Inc Company Overview
5.100 Surgical Energetics LLC Company Overview
5.101 Surgical Sealants, Inc. Company Overview
5.102 Teijin Pharma Ltd Company Overview
5.103 Texas A&M University Company Overview
5.104 The Medicines Company Company Overview
5.105 Therus Corporation Company Overview
5.106 Thrombotargets Corp Company Overview
5.107 Tissue Regenix Ltd Company Overview
5.108 Tribos LLC Company Overview
5.109 Tricol Biomedical Inc Company Overview
5.110 United Health Products, Inc. Company Overview
5.111 University of Akron Company Overview
5.112 University of Grenoble Alpes Company Overview
5.113 University of Kansas Company Overview
5.114 University of Pennsylvania Company Overview
5.115 University of Toledo Company Overview
5.116 Virginia Commonwealth University Company Overview
5.117 WNDM Medical Inc Company Overview
5.118 WoundZipper Inc Company Overview
5.119 Xcede Technologies Inc Company Overview
6 Wound Closure Devices- Recent Developments
6.1 Jun 19, 2018: Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer
6.2 Jun 15, 2018: Arch Therapeutics Completes Enrollment and Initiates Dosing in Skin Sensitization Study
6.3 Jun 14, 2018: SAM XT Extremity Tourniquet Awarded JEMS Hot Product
6.4 Jun 07, 2018: MiMedx to restate certain historical financial statements
6.5 Jun 07, 2018: MiMedx Announces Executive to Lead its International Operations and Provides Update on Company's International Progress
6.6 Jun 06, 2018: Advanced Medical Solutions announces retirement of CFO
6.7 Jun 05, 2018: Johnson & Johnson Announces Progress Toward Health for Humanity Goals
6.8 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
6.9 Jun 04, 2018: Owens & Minor Appoints Interim Chief Financial Officer, as well as a Chief Accounting Officer
6.10 Jun 04, 2018: Cesca Therapeutics Announces Reduction in Operating Expenses
6.11 May 31, 2018: Kuros Biosciences to Propose Appointment of New Board Members at AGM
6.12 May 31, 2018: Merit Medical Announces Leadership Change and Appointment of Interim CFO
6.13 May 28, 2018: Beactica Signs Three-Year Extension Agreement With Sanofi
6.14 May 28, 2018: Covalon Announces Major Corporate Initiatives and Second Quarter Results
6.15 May 25, 2018: Hollister Announces Grand Opening of New Distribution Center in Oud Gastel, Netherlands
6.16 May 25, 2018: Grifols culminates a year of growth and approves the distribution of a record EUR 265 million in dividends
6.17 May 24, 2018: EndoClot Expands GI Hemostasis Portfolio With Launch of EndoClot Adhesive
6.18 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.19 May 24, 2018: YIT and Hollister signed an agreement to construct the second stage of a healthcare product factory in Lithuania
6.20 May 23, 2018: Grifols publishes its 2017 Corporate Responsibility Report as part of its commitment to transparency
6.21 May 21, 2018: Seikagaku Initiates a Clinical Trial for SI-449, an Adhesion Barrier
6.22 May 21, 2018: Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference
6.23 May 14, 2018: Cesca Therapeutics Reports First Quarter 2018 Financial Results
6.24 May 10, 2018: Partnership Agreement concluded with DEMEDIC regarding sales and marketing of absorbable local hemostat “PuraStat” in Argentina
6.25 May 09, 2018: Sanofi lays off 95 workers in Framingham
6.26 May 08, 2018: Arch Therapeutics Provides Update on Study Initiation and 510(k)
6.27 May 08, 2018: Arch Therapeutics Provides Update on Study Initiation and 510(k)
6.28 May 08, 2018: Sanofi Announces Appointment of Mr. Charles Billard as Chief Financial Officer and Key Managerial Personnel
6.29 May 08, 2018: ACell Names Nino Pionati Vice President, International and Business Development
6.30 May 08, 2018: Smith & Nephew: Change of Directorate
6.31 May 07, 2018: FDA permits marketing of new endoscopic device for treating gastrointestinal bleeding
6.32 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.33 May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility
6.34 May 07, 2018: Covalon Announces Major Sales Breakthrough – Wins Contracts with an Estimated Value of $100 Million Over a Three-Year Period
6.35 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report
6.36 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018
6.37 May 03, 2018: Grifols increases its net profit by 7% to Euros 143 million and delivers significant growth in organic sales
6.38 May 02, 2018: Urgent Medical Device Recall: SAM XT Extremity Tourniquet
6.39 May 02, 2018: Biom’up Finalizes U.S. Commercial Organization to Support U.S. Launch of HEMOBLAST Bellows
6.40 May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results
6.41 May 02, 2018: Anika Reports First Quarter 2018 Financial Results
6.42 May 01, 2018: United Health Products Expands Animal Testing for HemoStyp in Support of PMA Application, Human Trials to Follow
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Wound Closure Devices - Pipeline Products by Stage of Development
Table 2: Wound Closure Devices - Pipeline Products by Segment
Table 3: Wound Closure Devices - Pipeline Products by Territory
Table 4: Wound Closure Devices - Pipeline Products by Regulatory Path
Table 5: Wound Closure Devices - Pipeline Products by Estimated Approval Date
Table 6: Wound Closure Devices - Ongoing Clinical Trials
Table 7: Wound Closure Devices Companies - Pipeline Products by Stage of Development
Table 8: Wound Closure Devices - Pipeline Products by Stage of Development
Table 9: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 10: PuraStat Hemostat - Product Status
Table 11: PuraStat Hemostat - Product Description
Table 12: TDM-511 - Product Status
Table 13: TDM-511 - Product Description
Table 14: 3-D Matrix Ltd - Ongoing Clinical Trials Overview
Table 15: PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery
Table 16: PuraStat Hemostat - Randomized Controlled Trial Comparing Purastat to Standard Therapy for Haemostasis Control During Endoscopic Submucosal Dissection
Table 17: Actamax Surgical Materials LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Actamax Adhesion Barrier - Product Status
Table 19: Actamax Adhesion Barrier - Product Description
Table 20: Actamax Surgical Materials LLC - Ongoing Clinical Trials Overview
Table 21: Actamax Adhesion Barrier - A Randomized, Controlled, Multi-center Study to Assess the Safety and Efficacy of Actamax Adhesion Barrier in Women undergoing Laparoscopic Abdominopelvic Surgery with a Myomectomy Followed by Second Look Laparoscopy (SLL)
Table 22: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 23: CUTIS - Product Status
Table 24: CUTIS - Product Description
Table 25: VIVO - Product Status
Table 26: VIVO - Product Description
Table 27: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: LiquiBand - Product Status
Table 29: LiquiBand - Product Description
Table 30: LiquiBand Exceed - Product Status
Table 31: LiquiBand Exceed - Product Description
Table 32: LiquiBand Flow Control - Product Status
Table 33: LiquiBand Flow Control - Product Description
Table 34: Next Generation Internal Fixation And Sealant Device - Product Status
Table 35: Next Generation Internal Fixation And Sealant Device - Product Description
Table 36: Advanced Medical Solutions Group plc - Ongoing Clinical Trials Overview
Table 37: LiquiBand Exceed - Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast Surgery
Table 38: Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: VersaWrap Adhesion Barrier - Product Status
Table 40: VersaWrap Adhesion Barrier - Product Description
Table 41: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Biohybrid Membrane - Product Status
Table 43: Biohybrid Membrane - Product Description
Table 44: Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Dural Sealant - Product Status
Table 46: Dural Sealant - Product Description
Table 47: Surgical Adhesive - Product Status
Table 48: Surgical Adhesive - Product Description
Table 49: Topical Adhesive - Product Status
Table 50: Topical Adhesive - Product Description
Table 51: Alumend LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Tissue-Bonding Adhesive - Product Status
Table 53: Tissue-Bonding Adhesive - Product Description
Table 54: Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Hemaseel HMN Fibrin Sealant - Product Status
Table 56: Hemaseel HMN Fibrin Sealant - Product Description
Table 57: Hemaseel Thrombin Haemostatic Agent - Product Status
Table 58: Hemaseel Thrombin Haemostatic Agent - Product Description
Table 59: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Hemostatic Patch - Product Status
Table 61: Hemostatic Patch - Product Description
Table 62: HYAFF Gel - Product Status
Table 63: HYAFF Gel - Product Description
Table 64: Hyaloglide - Product Status
Table 65: Hyaloglide - Product Description
Table 66: APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Deep Wound Hemostat - Product Status
Table 68: Deep Wound Hemostat - Product Description
Table 69: ARC Medical Devices Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Liquid Adhesion Reduction Device - Product Status
Table 71: Liquid Adhesion Reduction Device - Product Description
Table 72: Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: AC5 Surgical Hemostatic Device - Product Status
Table 74: AC5 Surgical Hemostatic Device - Product Description
Table 75: AC5 Surgical Hemostatic Device - Internal Use - Product Status
Table 76: AC5 Surgical Hemostatic Device - Internal Use - Product Description
Table 77: AC5 Topical Gel - Product Status
Table 78: AC5 Topical Gel - Product Description
Table 79: Aura Medsystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 80: LaSTR - Skin Closure Device - Product Status
Table 81: LaSTR - Skin Closure Device - Product Description
Table 82: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Hemopatch - Product Status
Table 84: Hemopatch - Product Description
Table 85: Tisseel Dura - Product Status
Table 86: Tisseel Dura - Product Description
Table 87: Baxter International Inc - Ongoing Clinical Trials Overview
Table 88: Hemopatch - A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (more than 5 Days - PAL)
Table 89: Hemopatch - A Prospective Randomized Trial of Hemopatch Versus No Hemopatch for the Intraoperative Hemostasis During Deceased Donor Renal Transplant
Table 90: Hemopatch - A Randomized, Controlled, Non-inferiority Study to Evaluate the Efficacy and Safety of Hemopatch Compared to TachoSil in Preventing or Reducing Postoperative Air Leaks After Pulmonary Resection
Table 91: Hemopatch - A Single-arm Phase II Trial of Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy
Table 92: Hemopatch - Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery
Table 93: Hemopatch - Exploratory Phase IV Randomized Single Blind Study Evaluating the Efficacy and Tolerability of Hemopatch in Improving Time of Hemostasis and Preventing Post-operative Complications After Hepatic Resection
Table 94: Hemopatch - Hemopatch Performance Evaluation: A Prospective Observational Registry
1.2 List of Figures
Figure 1: Wound Closure Devices - Pipeline Products by Stage of Development
Figure 2: Wound Closure Devices - Pipeline Products by Segment
Figure 3: Wound Closure Devices - Pipeline Products by Territory
Figure 4: Wound Closure Devices - Pipeline Products by Regulatory Path
Figure 5: Wound Closure Devices - Pipeline Products by Estimated Approval Date
Figure 6: Wound Closure Devices - Ongoing Clinical Trials 37

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report